Clorox Q1 FY2027 results
$109.46+1.16%
Clorox reported revenue of $1.91 billion, up 33.3% from a year earlier, net income of $170 million and diluted earnings per share of $1.39 against $0.65 for the first quarter of fiscal 2027 (the three months to 30 Sep 2026).
From its quarterly report, filed 2 Nov 2026. Compiled and checked by AapWire.
Q1 FY2027 against Q1 FY2026
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q1 FY2027 | Q1 FY2026 | Change |
|---|---|---|---|
| Revenue | $1.91B | $1.43B | +33.3% |
| Gross profit | $770.0M | $596.0M | +29.2% |
| Gross margin | 40.4% | 41.7% | −1.3 pts |
| Operating income | $259.0M | $130.0M | +99.2% |
| Operating margin | 13.6% | 9.1% | +4.5 pts |
| Net income | $170.0M | $80.00M | +113% |
| Diluted EPS | $1.39 | $0.65 | +114% |
| Operating cash flow | $143.0M | $93.00M | +53.8% |
| Capital expenditure | $38.00M | $36.00M | +5.6% |
| Free cash flow | $105.0M | $57.00M | +84.2% |
Operating KPIs for the quarter
| KPI | Q1 FY2027 | Change on a year |
|---|---|---|
| Health and Wellness revenue | $918.0M | up 62.5% |
| Household revenue | $423.0M | up 16.9% |
| Lifestyle revenue | $283.0M | up 15.5% |
| International revenue | $281.0M | up 11.1% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q1 FY2027 | 30 Sep 2026 | $1.91B | +33.3% | $1.39 |
| Q4 FY2026 | 30 Jun 2026 | $1.95B | −2.0% | $1.34 |
| Q3 FY2026 | 31 Mar 2026 | $1.67B | +0.1% | $1.54 |
| Q2 FY2026 | 31 Dec 2025 | $1.67B | −0.8% | $1.29 |
| Q1 FY2026 | 30 Sep 2025 | $1.43B | −18.9% | $0.65 |
| Q4 FY2025 | 30 Jun 2025 | $1.99B | +4.5% | $2.68 |
| Q3 FY2025 | 31 Mar 2025 | $1.67B | −8.0% | $1.50 |
| Q2 FY2025 | 31 Dec 2024 | $1.69B | −15.3% | $1.54 |
More on Clorox: financial statements · revenue · earnings per share
CLX's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
